Transcriptional signatures of the small intestinal mucosa in response to ethanol in transgenic mice rich in endogenous n3 fatty acids
- PMID: 33199802
- PMCID: PMC7670449
- DOI: 10.1038/s41598-020-76959-6
Transcriptional signatures of the small intestinal mucosa in response to ethanol in transgenic mice rich in endogenous n3 fatty acids
Abstract
The intestine interacts with many factors, including dietary components and ethanol (EtOH), which can impact intestinal health. Previous studies showed that different types of dietary fats can modulate EtOH-induced changes in the intestine; however, mechanisms underlying these effects are not completely understood. Here, we examined intestinal transcriptional responses to EtOH in WT and transgenic fat-1 mice (which endogenously convert n6 to n3 polyunsaturated fatty acids [PUFAs]) to identify novel genes and pathways involved in EtOH-associated gut pathology and discern the impact of n3 PUFA enrichment. WT and fat-1 mice were chronically fed EtOH, and ileum RNA-seq and bioinformatic analyses were performed. EtOH consumption led to a marked down-regulation of genes encoding digestive and xenobiotic-metabolizing enzymes, and transcription factors involved in developmental processes and tissue regeneration. Compared to WT, fat-1 mice exhibited a markedly plastic transcriptome response to EtOH. Cell death, inflammation, and tuft cell markers were downregulated in fat-1 mice in response to EtOH, while defense responses and PPAR signaling were upregulated. This transcriptional reprogramming may contribute to the beneficial effects of n3 PUFAs on EtOH-induced intestinal pathology. In summary, our study provides a reference dataset of the intestinal mucosa transcriptional responses to chronic EtOH exposure for future hypothesis-driven mechanistic studies.
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs.Int J Mol Sci. 2021 Feb 4;22(4):1582. doi: 10.3390/ijms22041582. Int J Mol Sci. 2021. PMID: 33557303 Free PMC article.
-
Decreased ω-6:ω-3 PUFA ratio attenuates ethanol-induced alterations in intestinal homeostasis, microbiota, and liver injury.J Lipid Res. 2019 Dec;60(12):2034-2049. doi: 10.1194/jlr.RA119000200. Epub 2019 Oct 4. J Lipid Res. 2019. PMID: 31586017 Free PMC article.
-
Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice.FASEB J. 2021 Feb;35(2):e21377. doi: 10.1096/fj.202001202R. FASEB J. 2021. PMID: 33481293 Free PMC article.
-
Effect of dietary fat on intestinal inflammatory diseases.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:33-6. doi: 10.1111/jgh.12252. J Gastroenterol Hepatol. 2013. PMID: 24251701 Review.
-
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22. Crit Rev Food Sci Nutr. 2019. PMID: 30580553 Review.
Cited by
-
Current View on the Mechanisms of Alcohol-Mediated Toxicity.Int J Mol Sci. 2021 Sep 7;22(18):9686. doi: 10.3390/ijms22189686. Int J Mol Sci. 2021. PMID: 34575850 Free PMC article. Review.
-
Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs.Int J Mol Sci. 2021 Feb 4;22(4):1582. doi: 10.3390/ijms22041582. Int J Mol Sci. 2021. PMID: 33557303 Free PMC article.
-
Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice.FASEB J. 2023 Jan;37(1):e22705. doi: 10.1096/fj.202200778R. FASEB J. 2023. PMID: 36520060 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- P20 GM113226/GM/NIGMS NIH HHS/United States
- P20GM113226/GM/NIGMS NIH HHS/United States
- P50 AA024337/AA/NIAAA NIH HHS/United States
- R01AA024102-01A1/NH/NIH HHS/United States
- P20GM103436/NH/NIH HHS/United States
- U01 AA026936/AA/NIAAA NIH HHS/United States
- F32 AA027950/AA/NIAAA NIH HHS/United States
- T32 ES011564/ES/NIEHS NIH HHS/United States
- U01 AA026980/AA/NIAAA NIH HHS/United States
- I01BX000350/VA/VA/United States
- R01 AA023681/AA/NIAAA NIH HHS/United States
- U01AA022489/NH/NIH HHS/United States
- I01 BX000350/BX/BLRD VA/United States
- T32ES011564/NH/NIH HHS/United States
- R01 AA024102/AA/NIAAA NIH HHS/United States
- P50AA024337/AA/NIAAA NIH HHS/United States
- L30 AA027913/AA/NIAAA NIH HHS/United States
- 1F32AA027950/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases